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1. Introduction
There are five major classes of steroid hormones: testosterone (androgen), estradiol (estro‐
gen), progesterone (progestin), cortisol/corticosterone (glucocorticoid), and aldosterone
(mineralocorticoids). Testosterone and its more potent metabolite dihydrotestosterone
(DHT), progesterone and estradiol are classified as sex-steroids, whereas cortisol/corticoster‐
one and aldosterone are collectively referred to as corticosteroids.
Sex steroids are crucial hormones for the proper development and function of the body; they
regulate sexual differentiation, the secondary sex characteristics, and sexual behavior pat‐
terns. Sex hormones production is sexually dimorphic, and involves differences not only in
hormonal action but also in regulation and temporal patterns of production. Gonadal sex ste‐
roids effects are mediated by slow genomic mechanisms through nuclear receptors as well as
by fast nongenomic mechanisms through membrane-associated receptors and signaling cas‐
cades. The term sex steroids is nearly always synonymous with sex hormones (Wikipedia).
Steroid hormones in mammals regulate diverse physiological functions such as reproduc‐
tion, mainly by the hypothalamic-pituitary-gonadal axis, blood salt balance, maintenance of
secondary sexual characteristics, response to stress, neuronal function and various metabolic
processes(fat, muscle, bone mass). The panoply of effects, regulations and interactions of go‐
nadal sex steroids in mammals is in part discussed in this chapter.
2. Production of gonadal steroids
Cholesterol is found only in animals; it is not found in plants although they can produce
phytoestrogens from cholesterol-like compounds called phytosterols.
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Because cholesterol cannot be dissolved in the blood, it must be carried through the body on
a "carrier" known as a lipoprotein. A lipoprotein is cholesterol covered by protein. There are
two types of liproproteins-LDL (low density lipoprotein) and HDL (high density lipopro‐
tein). All steroid hormones are synthesized from cholesterol through a common precursor
steroid, pregnenolone, which is formed by the enzymatic cleavage of a 6-carbon side-chain
of the 27- carbon cholesterol molecule, a reaction catalyzed by the cytochrome P450 side-
chain cleavage enzyme (P450scc, CYP11A1) at the mitochondria level (Figure 1a). The ovari‐
an granulosa cells mainly secrete progesterone (P4) and estradiol (E2); ovarian theca cells
predominantly synthesize androgens,and ovarian luteal cells secrete P4 (and its metabolite
20α-hydroxyprogesterone (Hu et al., 2010). Progesterone is also synthesized by the corpus
luteum and by the placenta in many species as it will be mentioned later. Testicular Leydig
cells are the site of testosterone (T) production. The brain also synthesizes steroids de novo
from cholesterol through mechanisms that are at least partly independent of peripheral ster‐
oidogenic cells. Such de novo synthesized brain steroids are commonly referred to as neuro‐
steroids. In mammals, the adrenal or suprarrenal glands are endocrine glands that produce
at the outer adrenal cortex androgens such as androstenedione.
All these steroidogenic tissues and cells have the potential to obtain cholesterol for steroid
synthesis from at least four potential sources: a) cholesterol synthesized de novo from ace‐
tate;b) cholesterol obtained from plasma low-density lipoprotein (LDL) and high-density
lipoprotein (HDL); c) cholesterol-derived from the hydrolysis of stored cholesterol esters in
the form of lipid droplets; and d) cholesterol interiorized from the plasma membrane, all
this mechanisms implicating cell organels such as smooth endoplasmic reticuli, endosomes
and of course mitochondria (Figure 1b). Although all three major steroidogenic organs
(adrenal, testis and ovary) can synthesize cholesterol de novo under the influence of the
tropic hormone, the adrenal and ovary preferentially utilize cholesterol supplied from plas‐
ma LDL and HDL via the LDL-receptor mediated endocytic pathway.
The use of LDL or HDL as the source of cholesterol for steroidogenesis appears to be species
dependent; rodents preferentially utilize the SR-BI/selective pathway; this is a process in
which cholesterol is selectively absorbed while the lipoprotein (mainly HDL) remains at the
cell surface. The discovery of a specific receptor for this process (scavenger receptor class B,
type I, known as SR-BI) has revolutionized the knowledge about the selective uptake path‐
way as a means of achieving cholesterol balance (Azhar et al., 2003).
Humans, pigs and cattle primarily employ the LDL/LDL-receptor endocytic pathway to
meet their cholesterol need for steroid synthesis. In contrast, testicular Leydig cells under
normal physiological conditions rely heavily on the use of endogenously synthesized cho‐
lesterol for androgen (testosterone) biosynthesis (Hu et al., 2010).
2.1. Ontogeny and sexual dimorphism
Steroidogenesis of gonadal sex hormones is by definition sexually dimorphic in hormonal
action and also in regulation and temporal patterns of production.
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Figure 1. Gonadal Steroids Synthesis Pathway. Modified from (Stocco, 2006; Senger, 2006). a) Steroidogenic tissues:
adrenal gland, placenta, ovary, testis. Cholesterol from food intake is used (as LDL and HDL in plasma) by different cells
in those tissues to synthesize the commune precursor: pregnenolone. The cascade continue with the androgens and
estrogens production. b) Production of pregnenolone from four potential cholesterol sources: 1. synthesized de novo
from acetate; 2. from plasma low-density lipoprotein (LDL) and high-density lipoprotein (HDL); 3. from the hydrolysis
of stored cholesterol esters in the form of lipid droplets; and 4. Interiorized from the plasma membrane; cell organels
implicated: smooth endoplasmic reticuli, endosomes and mitochondria
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2.1.1. Males
The mesoderm-derived epithelial cells of the sex cords in developing testes become the Ser‐
toli cells which will function to support sperm cell formation. A minor population of non-
epithelial cells appears between the tubules by week 8 of human fetal development. These
are Leydig cells. Soon after they differentiate, Leydig cells begin to produce androgens as
mentioned before. In humans, Leydig cell populations can be divided into fetal Leydig cells
that operate prenatally, and the adult-type Leydig cells that are active postnatally. Fetal Ley‐
dig cells are the primary source of testosterone and other androgens which regulate not only
the masculinization of external and internal genitalia but also neuroendocrine function af‐
fecting behavioral and metabolic patterns.
Interestingly, adrenocortical and gonadal steroidogenic cells seem to share an embryonic
origin in the coelomic epithelium, and they may exist as one lineage before divergence into
the gonadal and adrenocortical paths. A common origin is also supported by the testicular
adrenal rest tumours that are often found in male patients with congenital adrenal hyperpla‐
sia. Although much rarer, adrenal rests tumours have also been found in the ovary, also
supporting the concept of a common origin of the steroidogenic cells. Those prenatal steroi‐
dogenic Leydig cells undergo degeneration and it is not well know which paracrine or endo‐
crine factor(s) in the human fetal testis control this involution. Experiments on rodents have
indicated that the regression of fetal Leydig cells occurs when plasma levels of LH remain
high, suggesting that this gonadotropin cannot protect the cells from involution. It has been
suggested that several factors – e.g. tumour growth factor b (TGFb), anti-Müllerian hormone
(AMH), gonadotropin-releasing hormone (GnRH) –might play a role in fetal Leydig cell de‐
generation in rodents. TGFb is an attractive candidate for this purpose, since this factor is
expressed by fetal Leydig cells during late fetal life and potently inhibits fetal Leydig-cell
steroidogenesis in vitro.
It has been suggested that the development of human Leydig cells is triphasic and compris‐
es fetal Leydig cells that function during the fetal period, neonatal Leydig cells that operate
during the first year of life, and adult-type Leydig cells that appear from puberty onwards.
This hypothesis is based on the triphasic developmental profile of plasma testosterone levels
during human development.
All morphological modifications are accompanied by cellular growth and increasing expres‐
sion of steroidogenic enzymes and LH receptors. These cellular events significantly enhance
the capacity of mature Leydig cells to produce testosterone. Interestingly, reports in humans
and experimental animals demonstrate that fully mature Leydig cells can dedifferentiate to
previous stages of their development. These cellular events involve several morphological
changes such as a reduction of the smooth endoplasmic reticulum and numbers of mito‐
chondria, and impairment of T secretion. Paracrine control of Leydig cells steroidogenesis
have been reported. Ghrelin appear to be appropriate markers for estimating the phase of
Leydig-cell differentiation and the functional state of the cells. Leptin is another endocrine/
paracrine factor that can modulate Leydig-cell steroidogenesis signalling transduction path‐
way(s) as a negative control in human Leydig cells. In a recent work we suggested a possi‐
ble direct effect of leptin on calves gonads until the onset of puberty. The correlation
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between the expression of leptin receptors (OBR) isoforms and their association with leptin
and testosterone concentrations also indicated the complementary action of receptors and
those hormones in peripubertal calves testis (Ruiz-Cortes and Olivera, 2010). Platelet-de‐
rived growth factor (PDGF), vascular endothelial growth factor (VEGF) and endothelin and
their receptors have been reported to be expressed in normal human Leydig cells, and have
been suggested to play a role in the autocrine/paracrine regulation of human Leydig cell
physiology (Svechnikov and Söder, 2008).
2.1.2. Females
In the ovary, the cellular contribution to steroidogenesis is very different from that in the tes‐
tis, and both granulosa cells and theca cells contribute to steroidogenesis. In the testis support‐
ing cell lineage gives rise to Sertoli cells which are nurse cells for spermatogenesis. For ovarian
histogenesis, the supporting cell lineage gives rise to granulosa cells. Theca cells develop from
stromal steroidogenic precursor cells outside the follicles and are ovarian counterparts of Ley‐
dig cells. The theca cells synthesize androgen in response to human chorionic gonadotropin,
hCG and pituitary LH, but are not capable of producing estrogen since they lack expression of
CYP19 aromatase, the enzyme converting androgen to estrogen. This enzyme is expressed by
granulosa cells and these cells can produce estrogen and progesterone in response to LH and
FSH stimulation. Thus, both theca cells and granulosa cells are required for estrogen synthesis
by the ovary, and both gonadotropins (LH, FSH) are needed. These joint actions form the basis
of the two cell, two-gonadotropin hypothesis for biosynthesis of estrogen. This is much more
complex than the straight forward situation in the testis where Leydig cells produce androgen
in response to LH (or hCG)(Svechnikov and Söder, 2008).
In the female, as in male, leptin excerts important action on steroidogenesis. We proved that
Leptin, acting through STAT-3, modulates steroidogenesis in a biphasic and dose-depend‐
ent manner, and SREBP1 induction of StAR expression may be in the cascade of regulatory
events in porcine granulosa cells (Ruiz-Cortes et al., 2003).
2.2. Androgens and anabolic steroids
2.2.1. Androgens
Scientists have studied androgens since the 18th century. Androgens are dubbed the male
hormones mainly because males make and use more testosterone and other androgens than
females. These steroid hormones confer masculinity by triggering and controlling body pro‐
grams that govern male sexual development and physique. In females, androgens play
more subtle roles (Tulane University).
The androgens, as paracrine hormones, are required by the Sertoli cells in order to support
sperm production. They are also required for masculinization of the developing male fetus
(including penis and scrotum formation)(Table 1). Under the influence of androgens, rem‐
nants of the mesonephron, the Wolffian ducts, develop into the epididymis, vas deferens
and seminal vesicles. This action of androgens is supported by a hormone from Sertoli cells,
Gonadal Sex Steroids: Production, Action and Interactions in Mammals
http://dx.doi.org/10.5772/52994
7
MIH (Müllerian inhibitory hormone), which prevents the embryonic Müllerian ducts from
developing into fallopian tubes and other female reproductive tract tissues in male embryos.
MIH and androgens cooperate to allow for the normal movement of testes into the scrotum.
Two weak androgens, dehydroepiandrosterone and androstenedione are mostly synthe‐
sized in adrenal glands (in small amounts also in the brain). Androstenedione is converted
into T mainly in testis Leydig cells and peripheral tissue, or aromatized into estradiol. Tes‐
tosterone is metabolized by 5a-reductase in the potent androgen 5a-dihydrotestosterone and
like androstenedione in estradiol by P450-aromatase (also called estrogen synthase) (Figure
1) (Michels and Hoppe, 2008).
In humans, the role of androgens with respect to breast growth and neoplasia was evaluat‐
ed. Measurement of circulating sex steroids and their metabolites demonstrates that andro‐
gen activity is normally quite abundant in healthy women throughout the entire life cycle.
Epidemiological studies investigating T levels and breast cancer risk have major theoretical
and methodological limitations and do not provide any consensus. The molecular epidemi‐
ology of defects in pathways involved in androgen synthesis and activity in breast cancer
holds great promise but is still in early stages. Clinical observations and experimental data
indicate that androgens inhibit mammary growth and have been used with success similar
to that of tamoxifen to treat breast cancer. Given these considerations, it is of concern that
current forms of estrogen (E) treatment in oral contraceptives and for ovarian failure result
in suppression of endogenous androgen activity. Thus, there is need for studies on the
efficacy of supplementing both oral contraception and E replacement therapy with physio‐
logical replacement androgen, perhaps in a non aromatizable form, to maintain the natural
E–androgen ratios typical of normal women (Dimitrakakis et al., 2002).
2.2.2. Anabolic steroids
Anabolic steroids are synthetic derivatives of testosterone and are characterized by their
ability to cause nitrogen retention and positive protein metabolism, thereby leading to in‐
creased protein synthesis and muscle mass. Primary therapeutic use of testosterone is for re‐
placement of androgen deficiencies in hypogonadism. These compounds are used for
gynecologic disorders, anemia, osteoporosis, aging and treatment of delayed puberty in
boys. Anabolic steroids have also been taken to improve athletic performance to enhance
muscle development and to reduce body fat (Sevin et al., 2005).
According to surveys and media reports, the legal and illegal use of these drugs is gaining
popularity. Testosterone restores sex drive and boosts muscle mass, making it central to 2 of
society's rising preoccupations: perfecting the male body and sustaining the male libido.
Testosterone has potent anabolic effects on the musculoskeletal system, including an in‐
crease in lean body mass, a dose-related hypertrophy of muscle fibers, and an increase in
muscle strength. For athletes requiring speed and strength and men desiring a cosmetic
muscle makeover, illegal steroids are a powerful lure, despite the risk of side effects. Recent
clinical studies have discovered novel therapeutic uses for physiologic doses of anabolic-an‐
drogens steroids (AAS), without any significant adverse effects in the short term. In the
wake of important scientific advances during the past decade, the positive and negative ef‐
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fects of AAS warrant reevaluation (Evans, 2004). In 1991 testosterone and related AAS were
declared controlled substances. However, the relative abuse and dependence liability of
AAS have not been fully characterized. In humans, it is difficult to separate the direct psy‐
choactive effects of AAS from reinforcement due to their systemic anabolic effects. However,
using conditioned place preference and self-administration, studies in animals have demon‐
strated that AAS are reinforcing in a context where athletic performance is irrelevant. Fur‐
thermore, AAS share brain sites of action and neurotransmitter systems in common with
other drugs of abuse. In particular, recent evidence links AAS with opioids. In humans, AAS
abuse is associated with prescription opioid use. In animals, AAS overdose produces symp‐
toms resembling opioid overdose, and AAS modify the activity of the endogenous opioid
system (Wood, 2008).
Antiandrogens prevent or inhibit the biological effects of androgens. They are often indicat‐
ed to treat severe male sexual disorders such as paraphilias, as well as use as an antineoplas‐
tic agent in prostate cancer. They can also be used for treatment prostate enlargement, acne,
androgenetic alopecia and hirsutism. The administration of antiandrogens in males can re‐
sult in slowed or arrested development or reversal of male secondary sex characteristics,
and hyposexuality (Sevin et al., 2005).
2.3. Estrogens and progestogens
Estrogens, or oestrogens, are a group of compounds named for their importance in the es‐
trous cycle of humans and other animals. They are the primary female sex hormones. Natu‐
ral estrogens are steroid hormones, while some synthetic ones are non-steroidal. Estrogen
can be broken down into three distinct compounds: estrone, estradiol and estriol. During a
mammal reproductive life, which starts with the onset of puberty and continues until andro‐
pause and /or menopause (in human), the main type of estrogen produced is estradiol. En‐
zymatic actions produce estradiol from androgens. Testosterone contributes to the
production of estradiol, while the estrogen estrone is made from androstenedione. Phytoes‐
trogens have analogous effects to those of human estrogens in serving to reduce menopaus‐
al symptoms, as well as the risk of osteoporosis and heart disease. In Animal husbandry
(sheep and cattle) they may also have important physiological and sometimes deleterious
reproductive effects as they are present in some pastures plants such as soybean, Alfalfa, red
clover, white clover, subterranean clover, Berseem clover, birdsfoot trefoil and in native
American legumes such as Vicia americana and Astragalus serotinus (Adams, 1995). Other
estrogen containing foods Include: Anise seed, Apples, Baker's yeast, Barley, Beets, Carrots,
Celery, Cherries, Chickpeas, Clover, Cucumbers, Dates, Eggs, Eggplant, Fennel, Flaxseed,
Garlic, Lentils, Licorice, Millet, Oats, Olives, Papaya, Parsley, Peas, Peppers, Plums, Pome‐
granates, Potatoes, Pumpkin, Red beans, Rhubarb, Rice, Sesame seeds, Soybean sprouts,
Soybeans, Split peas, Sunflower seeds, Tomatoes, Wheat, Yams.
Progestogens are characterized by their basic 21-carbon skeleton, called a pregnane skeleton
(C21). In similar manner, the estrogens possess an estrane skeleton (C18) and androgens, an
andrane skeleton (C19) (Figure 1). Progestogens are named for their function in maintaining
pregnancy (pro-gestational), although they are also present at other phases of the estrous
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and menstrual cycles. The progestogen class of hormones includes all steroids with a preg‐
nane skeleton, that is, both naturally occurring and synthetic ones. Exogenous or synthetic
hormones are usually referred to as progestins.
Progesterone is the major naturally occurring human progestogen. Progesterone (P4) is pro‐
duced by the corpus luteum in all mammalian species. Luteal cells possess the necessary en‐
zymes to convert cholesterol to pregnenolone (P5), which is subsequently converted into P4.
Progesterone is highest in the diestrus phase of the estrous cycle as is going to be explained.
2.3.1. Estradiol
Estradiol (E2 or 17β-estradiol, also oestradiol) is a sex hormone. Estradiol has 17 carbons
(C17) and 2 hydroxyl groups in its molecular structure, estrone has 1 (E1) and estriol has 3
(E3). Estradiol is about 10 times as potent as estrone and about 80 times as potent as estriol
in its estrogenic effect. Except during the early follicular phase of the menstrual cycle, its se‐
rum levels are somewhat higher than that of estrone during the reproductive years of the
human female. Thus it is the predominant estrogen during reproductive years both in terms
of absolute serum levels as well as in terms of estrogenic activity. During menopause, es‐
trone is the predominant circulating estrogen and during pregnancy estriol is the predomi‐
nant circulating estrogen in terms of serum levels. Estradiol is also present in males, being
produced as an active metabolic product of testosterone. The serum levels of estradiol in
males (14 - 55 pg/mL) are roughly comparable to those of postmenopausal women (< 35 pg/
mL). Estradiol in vivo is interconvertible with estrone; estradiol to estrone conversion being
favored. Estradiol has not only a critical impact on reproductive and sexual functioning, but
also affects other organs, including the bones (Table 1).
There is scientific literature that may be relevant about the use of estradiol from the point of
view of food safety. In cattle for example Estradiol benzoate (10-28 mg) or estradiol-17ß (es‐
tradiol; 8-24 mg) is administered (orally) to cattle to increase the rate of weight gain (i.e.
growth promotion) and to improve feed efficiency. Estradiol valerate is also administered
by subcutaneous or intramuscular injection to synchronize estrus in cattle. Estradiol is gen‐
erally considered to be inactive when administered orally due to gastrointestinal and/or
hepatic inactivation.
Circulating estradiol, like T, is bound to sex hormone-binding globulin (SHBG, in Figure 4)
and, to a lesser extent, serum albumin. Only 1-2% of circulating estradiol is unbound; 40% is
bound to SHBG and the remainder to albumin. Plasma SHBG is secreted from the liver; a
similar, non-secretory form is present in many tissues, including reproductive tissues and
the brain.
Urinary and faecal metabolites of estrogens in animals and humans have been studied for
use as possible indicators of risk for hormone-dependent cancers or for infertility. There is at
present no consensus about the importance of specific metabolites or metabolite ratios as
prognostic factors, with the possible exception of estriol as a marker of the well-being of the
feto-placental unit (World Health Organization International Programme on Chemical Safe‐
ty, 2000).
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Estrogens have been isolated from testes of stallion, bulls, boars, dogs and men. Estrogens
may play a role in the pathogenesis of prostatic hyperplasia common in aged dogs, and es‐
trogens receptors are present in prostatic urethra and prostatic glands of dogs. Estrogens
like androgens, are transferred from testicular vein to the testicular artery. In several species,
levels of estrogens in the blood of testicular artery are consistently higher than the levels in
systemic blood. The mechanisms involved in the transfer of estrogens from vein to artery in
the pampiniform plexus and its physiology role are not clear. Estrogens may be playing im‐
portant role in regulating the pituitary-gonadal axis. In several species, estrogens inhibit
Leydig cell secretion of testosterone (Pineda, 2003) as it will be mentioned.
Name of Steroid
(abbrev.)
Steroidogenic Tissues Target Tissue (male and
female)
Physiological functions (male
and female)
Estradiol (E2) Granulosa cells of follicle
Placenta
Sertoli cells of testis
Brain, hypothalamus
Bones
Entire female reproductive tract
and mammary gland
Sexual behavior (male and female)
Secondary female sex
characteristics
GnRH regulation, Ovulation
Elevated secretory activity of the
entire female tract
Enhanced uterine motility
Regulation of cardiovascular
physiology
Bone integrity and neuronal
growth
Progesterone (P4) Luteinized/luteal cells
Placenta
Adrenal
Hypothalamus
Uterine endometrium,
myometrium
Mammary gland
Leydig cells
Follicular growth and ovulation
Endometrial secretion
Inhibits GnRH release
Inhibits reproductive behavior
Promotes maintenance of
pregnancy
Testosterone (T) Leydig cells of testis
Theca interna cells of ovary
Accesory sex glands (male)
Tunica dartos of scrotum
Seminiferous epithelium
Skeletal muscle
Brain (female)
Granulosa cells
Anabolic growth (male), Increase
muscle mass
Promotes spermatogenesis
Promotes secretion of accessory
sex glands
Substrate for E2 synthesis (female)
Secondary sex characteristics
Decrease risk of osteoporosis
Table 1. Sex steroids: Source, Target tissues and Physiological Functions. Modified from (Hu et al., 2010; Senger, 2006)
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2.3.2. Progesterone
Progesterone, also known as P4 (pregn-4-ene-3,20-dione), is a C-21 steroid hormone in‐
volved in the female menstrual/estral cycle, pregnancy and embryogenesis of humans and
other species. Progesterone is produced in the ovaries, the adrenal glands (suprarenal), and,
during pregnancy, in the placenta. Progesterone is also stored in adipose (fat) tissue. Proges‐
terone is synthesized by the ovarian corpus luteum, but during pregnancy the main source
of P4 is the placenta as in woman,mare and ewe; in cow, the time of placenta takeover is
6-8months of pregnancy. In other species (goat, sow, queen, bitch,rabbit, alpaca,camel, lla‐
ma) there is no placenta P4 production at all, the ovarian CL is in charge of the entire P4 for
gestation. In mammals, P4, like all other steroid hormones, is synthesized from pregneno‐
lone, which in turn is derived from cholesterol. Androstenedione can be converted to testos‐
terone, estrone and estradiol (Figure 1)(Wikipedia). Important functions of P4 are (1)
inhibition of sexual behavior; (2) maintenance of pregnancy by inhibiting uterine contrac‐
tions and promoting glandular development in the endometrium; and (3) promotion of al‐
veolar development of the mammary gland. The synergistic actions of estrogens and
progestins are notable in preparing the uterus for pregnancy and the mammary gland for
lactation (Table 1).
In at least one plant, Juglans regia, progesterone has been detected. In addition, progester‐
one-like steroids are found in Dioscorea mexicana. It contains a steroid called diosgenin that is
taken from the plant and is converted into progesterone. Diosgenin and progesterone are
found in other Dioscorea species as well.
The switch from the principal steroid product of the maturing follicle (estrogens) to that of
the developing and mature corpus luteum (P4) is one of the amazing hallmarks of the ovary
sex steroids production occurring during luteinization as described later.
Of interest, we have reported that during the differentiation of granulosa cells into luteal
cells in vitro, it exists an inverse modulation between the expression of LH receptors (LHR)
and the concentration of LH, and this expression of LHR could be regulated by P4 produced
by luteinized granulosa cells (Montaño et al., 2009).
3. Functional organization of the hypothalamic-pituitary-gonadal axis:
sex steroids control of reproduction
Gonadal secretory activites involve two special cell types responsive to FSH and LH. Ovarian
granulosa cells and testicular Leydig cells are responsive primarily to LH and synthesize andro‐
gens. Ovarian thecal cells and testicular Sertoli cells as well as Leydig cells respond to FSH with
conversion of androgens into estrogens (P450aromatase activity). FSH also stimulates Sertoli
cells to synthesize inhibin, activin, and other local bioregulatory factors (Norris, 2007).
12
3.1. Gonadal steroids and female reproductive cyclicity
Anatomically in the female hypothalamus, there are two GnRH neurons centers. The first, the
surge center, consists of three nuclei called the preoptic nucleus, the anterior hypothalamic area
and the suprachiasmatic nucleus. This center releases basal levels of GnRH until it receives the
appropriate positive stimulus. This stimulus is known to be a threshold level of estrogen in the
absence of P4. When the estrogen concentration in the blood reaches a certain level, a large
quantity of GnRH is released from the terminals of neurons, the cells bodies of which are locat‐
ed in the surge center. In natural condition, the preovulatory surge of GnRH occurs only once
during the estrous or menstrual cycle. The second, the tonic center, releases small episodes of
GnRH in a pulsatile fashion similar to a driping faucet. This episodic release is continuous and
throughout reproductive life and during the entire estrous cycle (Senger, 2006).
The female in various species have two important periods that mark the reproductive cycle:
follicular and luteal phases. The follicular phase begins after luteolysis that causes the de‐
cline in P4. Gonadotropins (FSH and LH) are therefore produced and cause follicles to pro‐
duce E2. The follicular phase is dominated by E2 produced by ovarian follicles and ends at
ovulation. The luteal phase begins after ovulation and includes the development of corpus
luteum that produces P4, and luteolysis that brought about by prostaglandin F2α. In wom‐
en, the follicular phase is divided into menses and proliferative period (5 and 9 days respec‐
tively); luteal phase is the secretory phase (14 days). In domestic animals, the follicular
phase is divided in pro-estrus (2 days) and estrus (1 day), and the luteal phase in metestrus
(4 days) and diestrus (14 days). At the pro-estrus, as P4 drops, FSH and LH increase togeth‐
er in response to GnRH. FSH and LH cause the production of E2 by ovarian follicles (Figure
2). When recruited follicles develop dominance, they produce E2 and inhibin that suppress‐
es FSH secretion from the anterior lobe of the pituitary. Thus, FSH does not surge with the
same magnitude as LH. The pre-ovulatory surge of GnRH is controlled by high E2 and low
P4. In mammals, including humans, E2 in the presence of low P4 exerts a differential effect
on GnRH. Thus, E2 in low concentrations causes a negative feedback (suppression) on the
preovulatory center. That is, low estrogen reduces the level of firing GnRH neurons in the
preovulatory-surge center. However, when E2 levels are high (estrus), as they would be
during the mid-to late follicular phase (figure 2), the preovulatory center responds dramati‐
cally by releasing large quantities of GnRH. This stimulation in response to rising concentra‐
tions of E2 is referred to as positive feedback. During the middle part of the cycle, when E2
levels are low and P4 is high (metestrus, diestrus), there is negative feedback on the preovu‐
latory center, thus preventing high amplitude pulses of GnRH. Interesting, when comparing
human vs. other mammals, the P4 does not influence sexual receptivity but in domestic ani‐
mals, those high levels of P4 inhibit it (Senger, 2006) (Figure 2).
As reviewed by Murphy, luteinization is a remarkable event involving cell proliferation, cell
differentiation, and tissue remodeling that is unparalleled in the adult mammal. It compris‐
es two major processes: (a) the terminated proliferation plus rapid hypertrophy and differ‐
entiation of the steroidogenic cells of follicle into the luteal cells of the CL. Luteinization is
both a qualitative and quantitative change because the mammalian CL produces up to 100-
fold greater amounts of steroid (P4) than the follicle. Luteolysis results in cessation of P4
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production, in structural regression to forma corpus albicans and into a follicular develop‐
ment and entrance into a new follicular phase.
P: Primordial follicle, PF: Primary follicle, SF: Secondary follicle, TF: Tertiary follicle, OF: Ovulatory follicle, Cl: Corpus lu‐
teum, Ca: Corpus albicans
Figure 2. Female cyclicity and gonadal steroids. Modified from (López et al., 2008; Senger, 2006) The two types of
reproductive cycles are the estrus and the menstrual cycles. Each cycle consists of a follicular and a luteal phase. The
follicular phase is dominated by the hormone E2 from ovarian follicles. E2 causes marked changes in the female tract
for pregnancy. Anestrus stands for periods of time when estrous cycles cease. Pregnancy, season of the year, lactation,
forms of stress and pathology cause anestrus. Amenorrhea refers to the lack of menstrual periods and is caused by
many of the same factors that cause anestrus. A menstrual cycle consists of the physiological events that occur be‐
tween successive menstrual periods (about 28 days). No endometrial sloughing (menstruations) occurs in animal with
estrous cycles.Lutealphase is dominated by P4 from corpus luteum.
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As the main steroid produced during luteal phase is the P4 it is important to mention about the
manipulation of the estrous and menstrual cycles by exogenous administration of P4. It serves
indeed as an “artificial corpus luteum” (ear subcutaneous implants or intravaginal devices).
Exogenous P4 suppresses estrus and ovulation. When this exogenous P4 is removed or with‐
drawn, the animal will enter pro-estrus and estrus within 2 to 3 days after removal. This appli‐
cation is intended to increase the convenience of artificial insemination programs and to
facilitate fertility in domestic husbandry animal (improving pregnancy rates). In contrast, the
use of exogenous P4 in humans (oral, transdermal,injectable, implants) is intended to block ov‐
ulation and minimize pregnancy probability (contraception)(Senger, 2006).
3.2. Gonadal steroids and spermatogenesis
Upon stimulation by LH, the Leydig cells of the testes produce androgens. Dihydrotestoster‐
one is found in high enough concentration in peripheral tissue to be of functional impor‐
tance. Functions of T, as states before, include (1) development of secondary sex
characteristics; (2) maintenance of the male duct system; (3) expression of male sexual be‐
havior (libido); (4) function of the accessory glands; (5) function of the tunica dartos muscle
in the scrotum; and (6) spermatocytogenesis. The role of T in regulating the release of hypo‐
thalamic and gonadotropic hormones is similar to that described for P4 in the female. High
concentrations of T inhibit the release of GnRH, FSH, and LH, a negative feedback control.
Conversely, when T concentrations are low, higher levels of GnRH, FSH, and LH are re‐
leased. Thus, reciprocal action of T with the hypothalamic and gonadotropic hormones is
necessary for regulation of normal reproduction in the male (Figure 3)(Gyeongsang Nation‐
al University). Luteinizing hormone acts on the Leydig cells within the testes. These cells are
analogous to the cells of the theca interna of antral follicles in the ovary. They contain mem‐
brane bound receptors for LH. When LH binds to their receptors, Leydig cells produce P4,
most of which is converted to T. The production of T takes place by the same intracellular
mechanism as in the female. The Leydig cells synthesize and secrete T less than 30 minutes
after the onset of an LH episode (Figure 3). This T secretion is short and pulsatile, lasting for
a period of 20 to 60 minutes. It is believed that pulsatile discharge of LH is important for two
reasons. First, high concentration of T within the seminiferous tubule is essential for sperma‐
togenesis (Senger, 2006). Second, Leydig cells become unresponsive to sustained high levels
of LH believed to be caused by reduction in the number of LH receptor. In fact, continual
high concentrations of LH result in reduced secretion of T. Intratesticular levels of T are
100-500 times higher than that of systemic blood. However, testicular T is diluted over 500
times when it reaches the peripheral blood (Senger, 2006). This dilution added to a short
half-life of the T (here, there is considerable variation in the half-life of testosterone as re‐
ported in the literature, ranging from 10 to 100 minutes; it is metabolized in the liver) keep
systemic concentrations well below that which would cause down-regulation of the
GnRH/LH feedback. The role of the pulsatile nature of T is not fully understood. It is be‐
lieved that chronically high systemic concentrations of T suppress FSH secretion. Sertoli
cells function is FSH dependent. Thus, their function is compromised when FSH is reduced.
The periodic reduction in T allows the negative feedback on FSH to be removed. But the ex‐
act role of this FSH diminution it is not clear as well as the physiological role of paracrine/
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autocrine inhibin effects within the testis has not been clarified. While the α subunit knock‐
out mouse model suggests that this protein protects against the development of testicular
tumours, there is no evidence for a physiological role of paracrine/autocrine inhibin signal‐
ling on spermatogenesis or steroidogenesis (de Kretser et al., 2001). Sertoli cells also produce
inhibin that, as in the female, suppresses FSH secretion from the anterior lobe of the pituita‐
ry. The physiologically important hormone that exerts tonic negative feedback upon FSH se‐
cretion in men is inhibin B (Illingworth et al., 1996). Inhibin and androgen binding protein
are produced by Sertoli cells under the influence of FSH. As in the female, inhibin selective‐
ly inhibits the release of FSH while not affecting the release of LH. Androgen binding pro‐
tein binds T, making it available for its functions in spermatozoa production.
Figure 3. Spermatogenesis and steroids. Modified from (Senger, 2006). There is a pulsatile discharge of LH. Leydig
cells produce important concentrations of testosterone (T).High concentration of T within the seminiferous tubule, es‐
sential for spermatogenesis. Sertoli cells aromatize T from Leydig cell into E2.
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Under the influence of FSH the Sertoli cells convert T to E2 and other estrogens (Figure 3).
The stallion and the boar secrete large amount of E2 but since they are secreted as molecules
with low physiologic activity they seem to be of little consecuence. Sertoli cells convert T to
E2 utilizing a mechanism identical to the granulosal cell of the antral follicle in the female
(Senger, 2006). The exact role of E2 in male reproduction it is not clear. The finding of both
aromatase and E2 receptors (ERs) in the developing fetal testis implies a possible involve‐
ment of estrogens in the process of differentiation and maturation of developing rodent tes‐
tis from an early stage of morphogenesis, probably ERβ having a major role than ERα
(Luconi et al., 2002; Rochira et al., 2005). Also, T and E2 in the blood act on the hypothala‐
mus and exert a negative feedback on GnRH and, in turn, LH and FSH are reduced.
3.3. Sex steroids molecular pathways in target tissues
Steroid hormones regulate cellular processes by binding to membrane, intracellular and/or nu‐
clear receptors that, in turn, interact with discrete nucleotide sequences to alter gene expres‐
sion. Because most steroid receptors in target cells are located in the cytoplasm, they need to
get into the nucleus to alter gene expression. This process typically takes at least 30 to 60 mi‐
nutes. In contrast, other regulatory actions of steroid hormones are manifested within seconds
to a few minutes. These time periods are far too rapid to be due to changes at the genomic level
and are therefore termed nongenomic or rapid actions, to distinguish them from the classical
steroid hormone action of regulation of gene expression. The rapid effects of steroid hormones
are manifold, ranging from activation of mitogen-activated protein kinases (MAPKs), adenyl‐
yl cyclase (AC), protein kinase C and A (PKC,PKA), and heterotrimeric guanosine triphos‐
phate-binding proteins (G proteins) (in Figure 4 and 5). In some cases, these rapid actions of
steroids are mediated through the classical steroid receptor that can also function as a ligand-
activated transcription factor, whereas in other instances the evidence suggests that these rap‐
id  actions  do  not  involve  the  classical  steroid  receptors.  One  candidate  target  for  the
nonclassical receptor-mediated effects are G protein-coupled receptors (GPCRs), which acti‐
vate several signal transduction pathways. One characteristic of responses that are not mediat‐
ed  by  the  classical  steroid  receptors  is  insensitivity  to  steroid  antagonists,  which  has
contributed to the notion that a new class of steroid receptors may be responsible for part of the
rapid action of steroids. Evidence suggests that the classical steroid receptors can be localized
at the plasma membrane, where they may trigger a chain of reactions previously attributed on‐
ly to growth factors. Identification of interaction domains on the classical steroid receptors in‐
volved in the rapid effects, and separation of this function from the genomic action of these
receptors, should pave the way to a better understanding of the rapid action of steroid hor‐
mones (Cato et al., 2002; Simoncini et al., 2004) (Figure 4 and 5).
3.3.1. Androgens
The biological activity of androgens is thought to occur predominantly through binding to
intracellular androgen-receptors, a member of the nuclear receptor family, that interact with
specific nucleotide sequences to alter gene expression. This genomic-androgen effect typical‐
ly takes at least half an hour. In contrast, the rapid or non-genomic actions of androgens are
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manifested within in seconds to few minutes. This rapid effect of androgens are manifold,
ranging from activation of G-protein coupled membrane androgen receptors or sex hor‐
mone-binding globulin receptors, stimulation of different protein kinases, to direct modula‐
tion of voltage- and ligand gated ion-channels and transporters. The physiological relevance
of these non-genomic androgen actions has not yet been determined in detail. However, it
may contribute to modulate several second messenger systems or transcription factors,
which suggests a cross-talk between the fast non-genomic and the slow genomic pathway of
androgens (Michels and Hoppe, 2008) (Figure 4).
The rapid actions of androgens are mediated by direct binding to the target protein (e.g.,
ion-channel) or by a specific association to different receptors. The non-genomic androgen
action based on receptor level can be mediated by at least three androgen-binding proteins,
the classical intracellular androgen receptor, the transmembrane androgen receptor and the
transmembrane sex hormone-binding globulin receptor. For both transmembrane receptors,
the non-genomic effect is converted via a G-protein coupled process, whereas binding to in‐
tracellular androgen receptors may lead to an activation of several cytosolic pathways. All
rapid androgen actions are predominantly mediated by second messenger signaling (espe‐
cially Ca2+) and phosphorylation events, including different intracellular signal routes, e.g.,
PKA, MAPK, phospholipase:PLC, phosphatidylinositol-3 kinase:PI-3K, steroid receptor co‐
activator:Src pathways. Although some studies implicated benefits of the non-genomic an‐
drogen actions on the cardiovascular and neuropsychiatric systems, more detailed research
and clinical studies are still required (Michels and Hoppe, 2008).
Increasing evidence suggests that nongenomic effects of testosterone and anabolic andro‐
genic steroids (AAS) operate concertedly with genomic effects. Classically, these responses
have been viewed as separate and independent processes, primarily because nongenomic
responses are faster and appear to be mediated by membrane androgen receptors, whereas
long-term genomic effects are mediated through cytosolic androgen receptors regulating
transcriptional activity. Numerous studies have demonstrated increases in intracellular
Ca2+ in response to AAS. These Ca2+ mediated responses have been seen in a diversity of
cell types, including osteoblasts, platelets, skeletal muscle cells, cardiac myocytes and neu‐
rons. The versatility of Ca2+ as a second messenger provides these responses with a vast
number of pathophysiological implications. In cardiac cells, testosterone elicits voltage-de‐
pendent Ca2+ oscillations and inositol-1,4,5-triphosphate receptors:IP3R mediated Ca2+ re‐
lease from internal stores, leading to activation of MAPK and the serine/threonine protein
kinase regulating cell growth, cell proliferation, cell motility, cell survival, protein synthesis,
and transcription: mTOR. In neurons, depending upon concentration, testosterone can pro‐
voke either physiological Ca2+ oscillations, essential for synaptic plasticity, or sustained,
pathological Ca2+ transients that lead to neuronal apoptosis. It was proposed that Ca2+ acts
as an important point of crosstalk between nongenomic and genomic AAS signaling, repre‐
senting a central regulator that bridges these previously thought to be divergent responses
(Vicencio et al., 2011).
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Figure 4. Actions and pathways of androgens. Modified from (Michels and Hoppe, 2008). The rapid effects of steroid
hormones are mediated by he activation of mitogen-activated protein kinases (MAPKs), adenylyl cyclase (AC), protein
kinase C and A (PKC,PKA), and heterotrimeric guanosine triphosphate-binding proteins (G proteins). The cross-talk be‐
tween the fast non-genomic and the slow genomic pathway by androgens binding to their internal androgens recep‐
tors (IAR) is mediated in part by intracellular Ca2+.
3.3.2. Estrogens
In 2009 Chariditi et al. described four main pathways of estrogen receptors (ERs) alpha (a)
and beta (b) signaling as a matter of “sophisticated” control systems necessary to obtain a
tight equilibrium in estrogen action and regulation of ER expression in tissues and cells
(Charitidi et al., 2009).
The first well known molecular mechanism is the classic ligand dependent pathways. Estro‐
gen receptors are kept inactive in the nucleus and cytoplasm of the cell forming a complex with
various heat shock proteins (hsp) that act as chaperones when the cell is not exposed to estro‐
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gens. Such proteins are hsp90, hsp70 and hsp56 and by forming a complex with the ERs they
are believed to prevent them from binding to their response elements EREs, but also keep them
capable of binding to their ligands (estrogens) with high affinity. When the estrogens diffuse
across the cell and nuclear membrane they interact with the inactive form of the ERs and sepa‐
rate them from the hsp-complex. ERs are now activated and can form homodimers and to a
lesser extent heterodimers to bind to their estrogens EREs. The EREs are commonly located in
the promoter regions of estrogen target genes and make it possible for the ERs to specifically
bind to the DNA and regulate transcription either as enhancers or repressors.
Once the complex of the activated ERs together with co-activator proteins (such as ligand-
dependent activation function-1 and 2: AF-1 and AF-2) is bound to the ERE it can either up-
or down-regulate the expression of the target gene. This is decided by whether the ERE is
‘‘positive” or ‘‘negative” in the particular cell type for the ERs as well as by the cellular mi‐
lieu (Figure 5).
The second molecular mechanism is the ligand independent. It is possible that the ERs get
activated even in the absence of their ligands with the aid of intracellular second messen‐
gers. Growth factors are able to activate MAPKs and they subsequently become phosphory‐
lated and thus activate the ERs. This ligand-independent ER activation is still dependent on
AF-1. Another intracellular path that can lead to ER activation in the absence of ligands is
via cAMP, a second messenger for G-protein coupled receptors and activates the PKA path‐
way. AF-2 is needed for cAMP activation of ERs. In this type of ligand-independent activa‐
tion of ERs, growth factors and second messengers take over estrogens part to induce/elicit
the same response from ERs (Figure 5).
The third signaling pathway is the ERE independent one. Estrogens exert their actions
through the two ERs but also through other transcription factors. In this case the ligand-acti‐
vated ERs do not bind to their EREs but anchor instead to other transcription factors directly
bound to DNA in their specific response elements. In this mechanism ERs act more as co-
regulators than actual transcription factors (activating protein-1 (AP-1), (Fos/Jun) or the
stimulating protein-1 (Sp1)). Thus this, pathway is also referred to as transcription factor
cross-talk (Figure 5)). Furthermore, the two ERs differ in their capacity to interact with dif‐
ferent transcription factors. For example in the presence of 17beta-estradiol, ERa induces
AP-1 driven gene transcription, while ERb has an inhibitory effect. This contrasting tran‐
scriptional activity is another example of the opposing actions of each ER.
The last mechanism is the non-genomic plasma-membrane pathway. The above mentioned
mechanisms include the relatively long processes of gene transcription and mRNA transla‐
tion and are thus insufficient to explain the short-term effects of estrogens that are found.
Intracellular pathways that increase intracellular calcium, cAMP, or the phosphorylation of
the cAMP response element binding protein (CREB), can result in an instantaneous response
of the cell. This pathway does not require transcription of genes via the ERs and is referred
to as non-genomic mechanisms of estrogen action, similar to the non-genomic pathways of
androgens (Charitidi et al., 2009) (Figure 5).
In adults, the interaction of estrogen genomic and nongenomic mechanisms may act to
maintain physiology or signal transduction pathways as hormone levels fluctuate across the
estrus cycle. As such, a disruption of the hormone/receptor system through a loss of hor‐
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mone, decreased receptor expression, or uncoupling of receptor-transcriptional activity due
to chronically elevated estrogen levels, would contribute to age-related changes that under‐
lie the progressive senescence of physiological processes. Treatments designed to increase
ER activity around the time of menopause, such as cyclic estrogen replacement, may be
more beneficial than chronic hormone replacement (Foster, 2005).
Figure 5. Actions and pathways of estrogens. Modified from (Charitidi et al., 2009). Four molecular mechanisms of E2
signaling in target cells. The first is the classic ligand dependent pathways. Estrogen receptors (ER) are liberated from
heat shock proteins complex (hsp) and can continue their nuclear-DNA effect. The second is the ligand independent. It
is possible that the ERs get activated even in the absence of their ligands with the aid of intracellular second messen‐
gers. The third is the ERE independent. In this case the ligand-activated ERs do not bind to their EREs but anchor in‐
stead to other transcription factors. The fourth is the non-genomic plasma-membrane pathway and does not require
transcription of genes via the ERs. Besides those well documented genomic and non- genomic molecular pathways, it
is important to mention the epigenetic regulation.
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Recently, it was published a review about the overlapping nongenomic and genomic actions
of thyroid hormone and estrogens and androgens. Authors concentrate on the tumor cell
model, where, for example, estrogens and thyroid hormone have similar MAPK-dependent
proliferative actions and where dihydrotestosterone also can stimulate proliferation. Ste‐
roids and thyroid hormone have similar anti-apoptotic effects in certain tumors; they also
have overlapping or interacting nongenomic and genomic actions in heart and brain cells.
Their possible clinical consequences seem of crutial importance for the potential endocrine
therapy targeting steroids receptors directly or indirectly (hormone or protein with overlap‐
ping effects) as reported for breast cancer and the nuclear and citoplasmic estrogen receptor
and aromatase (Davis et al., 2011; Levin and Pietras, 2008).
Estradiol epigenetic effects have been reported with results providing evidence for mitotic reg‐
ulation in follicle development by estrogen and demonstrate a previously undiscovered mech‐
anism for induction of cell proliferation in ovarian and mammary gland cells. This epigenetic
mark is induced by both FSH and 17beta-estradiol (E2), acting independently. E2-induced H3
phosphorylation fails to occur in mice with inactivated alpha-isoform of the nuclear estrogen
receptor. E2 induction of histone phosphorylation is attenuated by cell cycle inhibition. Fur‐
ther, E2 induces the activity of the mitotic kinase, Aurora B, in a mammary tumor cell model
where mitosis is estrogen receptor-alpha dependent (Ruiz-Cortes et al., 2005).
3.4. Reproductive moments and steroids
3.4.1. Puberty
Sex steroids regulation of the initiation of puberty was reported since 1979 in murine stud‐
ies. Immature female rats presented evidence of oestrogen secretion by day 32 of life and an
increased sensitivity of the pituitary to LHRH by day 34. These data suggested that in addi‐
tion to the increased release of GnRH during puberty, a sex steroid induced alteration in the
pituitary's responsiveness to GnRH may also be a significant contributory factor in the in‐
crease in secretion of gonadotropins at puberty. The stimulatory effect appeared to be relat‐
ed both to the quantity of sex steroid and the challenging dose of GnRH. These studies show
that in addition to changes in sensitivity at the level of the hypothalamus, the CNS and go‐
nads steroid and GnRH modulation of the response of the pituitary gland, are important
events in the onset of puberty (Mahesh and Nazian, 1979).
Puberty is associated with an increasing production of androgenic steroids. Adrenal andro‐
gen formation (adrenarche), may precede gonadal testosterone synthesis. Both adrenal and
gonadal androgens exert their biological effects via the androgen receptor, a nuclear tran‐
scription factor modulating a specific transcription regulation of largely unknown genes.
During puberty, virilizing actions such as genital enlargement and sexual hair growth can
be distinguished from anabolic action such as the gain in muscle strength and general
changes in body composition. Furthermore, androgens play a major role in the initiation
and maintenance of spermatogenesis. Thus, different androgenic steroids play an important
role in the process of puberty (Hiort, 2002)(Table 2).
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Male infants have a surge in T levels during the first few months of life. These levels fall to
quite low (but greater than in female infants and children) until the pubertal rise. Nighttime
elevations in serum T concentration are detectable even before the onset of the external signs
of pubertal development following the sleep-entrained rises in serum LH. The daytime lev‐
els rise later as the testis volume increases.Testosterone is a substrate for 5-a reductase (con‐
version to dihydrotestosterone) and for aromatase (conversion to estradiol). The effects on
muscle are likely in part due directly to T and indirectly to E2 because of the marked in‐
crease in growth hormone-GH and IGF-I levels due to an action of E2 on the hypothalamus
and pituitary (Rogol, 2002).
In domestic animals, Senger and his team very appropriately mentioned in his book how the
“story on the onset of puberty is not complete”. It is about many factors that may be control‐
ling this important physiological process of acquiring reproductive and productive compe‐
tence. This capability is influenced by achieving the appropriated energy metabolism/body
size and appropriated exposure to external modulators such as photoperiod (goat, sheep,
horse), size of social groups (pig, cow) and the presence of the male (cow, goat). Genetics of
the animal likely play a role in how these cues are generated within the animal (metabolic sig‐
nals) and /or perceived (external cues, metabolic signals). The exact mechanisms that enable
E2 to control GnRH secretion by the hypothalamus during the peripubertal period are still un‐
known even if since 1979 this effect was porposed as mentioned at the beginning of this apart.
Other factor that need better understanding is the effect of ferhormones (as social clue), in‐
cluding steroids hormones, on the control of puberty onset; olfactory and vomeronasal or‐
gans are  implicated but  the  exact  pathways is  not  well  defined.  Finally,  from a genetic
improvement/reproductive management standpoint, is of interest the goal of shortening the
time of onset of puberty, mainly in the male, in order to fasten the availability of spermatozoa
production (particulary for artificial insemination in bulls, swine and poultry), the generation
interval could be reduced and genetic improvement accelerated. Since female must maintain a
successful pregnancy, deliver live offspring and lactate, there a clearly physiological limit to
hastened puberty in females (Senger, 2006). The use of exogenous sex steroids for those pur‐
poses (male and female) is possible but also very questioned because of the secondary effects
and the potential food residues (meat and milk) for human. Interestingly, Nelson proposed
three potential predictors (i.e., biomarkers) of longevity in mammals (1) age of pubertal on‐
set, (2) concentrations of gonadal steroids and (3) timing of age-related infertility. Ages of pu‐
bertal  onset  and  of  declining  fertility  are  hypothesized  to  be  positively  correlated  with
longevity. Concentrations of androgens and estrogens are proposed to be inversely and posi‐
tively correlated, respectively, with life span (Nelson, 1988).
3.4.2. Fertilization
Thirty years ago research results about the effect of follicular steroids on the maturation and
fertilization of mammalian oocytes was reported. Pronuclear development was used to
measure the effects on ovine oocytes of altering follicular steroidogenesis during maturation
in vitro. Follicular steroid secretion was altered using enzyme inhibitors and exogenous ste‐
roid supplementation. Abnormalities induced during maturation were measured 24 h after
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transfer of oocytes to the oviducts of inseminated hosts. The authors concluded that oocytes
require a specific intra-follicular steroid environment for the completion of the full matura‐
tion process. Alterations to the steroid profile during maturation induce changes in the oo‐
cyte which are expressed as gross abnormalities at fertilization (Moor et al., 1980).
Similarly, in other study, oocytes were collected by aspiration of preovulatory follicles from
55 women. After collection and culture, the oocytes were inseminated with the spermatozoa
of the husband. The levels of progesterone, oestradiol-17β and androstenedione in the clear
follicular fluid were measured by radioimmunoassay. A multivariate analysis containing
these three hormone levels together with two ratios of progesterone with each of the other
hormones indicated reasonable discrimination between the oocytes which fertilized and
those which remained unfertilized after insemination. The discriminant analysis suggested
that the fertilization of the oocytes could have been predicted on the basis of these hormonal
profiles with a success rate which exceeded 90% (Fishel et al., 1983).
More recently, an academic article presents the result of a study on the correlation among
sex steroids in follicular fluid (FF) and cultured granulosa cells and fertilization. The study
examined the levels of E2, P4, and T in follicular fluid from stimulated cycles and their gran‐
ulosa cell cultures after oocyte retrieval and the correlation between these levels. It revealed
that there is no link among fertilization and sex steroid levels in FF and granulosa cells (Fer‐
tilityWeekly, 2011). This is an important recent report taking in account that now a day in
some in vitro fertilization –IVF- protocols, sexual steroids are commonly used as factor of
fertilization improvement. Also, high follicular fluid E2 may be a marker for oocytes that
will fertilize normally with intracytoplasmic sperm injection (ICSI) (Lamb et al., 2010).
At the spermatozoa level, in human it was demonstrated the expression of a functional sur‐
face estrogen receptor (of 29 KDa). Luconi et al., suggested that this receptor and of course
its ligand, may play a role in the modulation of non-genomic action (via calcium modula‐
tion) of P4 in spermatozoa during the process of fertilization: E2 stimulates tyrosine phos‐
phorylation of several sperm proteins, including the 29-KDa protein band, and determines a
reduction of calcium response to P4, finally resulting in modulation of P4-stimulated sperm
acrosome reaction in a dose-response manner (Luconi et al., 1999) (Table 2).
3.4.3. Gestation and placentation
The ontogeny and functional role of steroidogenesis during mammalian gestation is poorly
understood. A 2002 review provides a summary of findings on the spatio-temporal expres‐
sion of key steroidogenic genes controlling progesterone synthesis in the uterus during
mouse pregnancy. Authors have shown that onset of P450scc and an identified isoform of
murine 3beta-hydroxysteroid dehydrogenase/isomerase type VI (3betaHSD VI) expression
occurs upon decidualization of the uterine wall induced by implantation. This unexpected
early expression of the enzymes in the maternal decidua is terminated at mid-pregnancy
when the steroidogenic ability reappears in the extraembryonic giant cells at the time of pla‐
centation. The giant cells express the StAR protein. Unlike the human placenta, the steroido‐
genic genes are not expressed in the cells of the mature mouse placenta during the second
half of gestation. The results suggested that, during early phases of pregnancy, local P4 syn‐
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thesis in the maternal decidua and the trophoblast layers surrounding the embryonal cavity
is important for successful implantation and/or maintenance of pregnancy. It was proposed
that the local production of progesterone acts as an immunosuppressant at the materno fetal
interface preventing the rejection of the fetal allograft (Ben-Zimra et al., 2002).
Strauss III et al. published in 1996 a review on the placental steroidogenesis capacity includ‐
ing the evidence for a dialogue between the ovary and the pituitary and placenta. In some
mammals, the placenta eclipses the pituitary in the maintenance of ovarian function (e.g.,
mouse and rat). In human and in sheep, horse, cat, and guinea pig, the placenta acquires the
ability to substitute for the ovaries in the maintenance of gestation at various times during
pregnancy. They noted that even though the placentae of other species cannot substitute for
ovarian function, all placentae critically studied expressed steroidogenic enzymes. There‐
fore, the ability to elaborate or metabolize steroid hormones is one common feature of troph‐
oblast cells despite the marked differences in placental morphologies. In human, rhesus
monkey, baboon, and horse, the placenta does not express 17a-hydroxylase. Placental estro‐
gen synthesis in these species depends upon a source of androgen precursor from the fetus;
the fetal adrenal glands in the case of primates, the gonadal interstitial cells in the case of the
horse. In contrast, the trophoblast cells of rat, pig, sheep and cow express 17a-hydroxylase
and are able to synthesize androgens and in some species estrogens.
In the rat, estrogen, synthesized by the ovaries, suppresses placental expression of 17a-hy‐
droxylase. Since the rat placenta elaborates androgens that are potential precursors for ovar‐
ian aromatization, a dialogue between the placenta and ovary may take place in this species.
Estrogens not only regulate 17a-hydroxylase expression, they control placental mass. The rat
placenta hypertrophies in response to ovariectomy, and this hypertrophy is blocked by
exogenous estrogen. These findings support the notion of an ovarian-placental interaction
(Strauss et al., 1996) (Table2).
3.4.4. Parturition
Since 1983, Meinecke-Tillnann et al. described the changes in the plasma levels of estrone
and E2 during the estrous cycle, gestation and puerperium in the goat. Estrone sulphate and
E2 concentrations rose until the 12th week of gestation and then declined to about 50% of
the former ranges of concentrations before rising again to high values at weeks 17–20 of ges‐
tation. Increasing plasma levels of estrone sulphate and E2 were determined during the last
ten days preceding parturition. The concentrations of estrone sulphate returned to basal lev‐
els by the 2nd-4th day post partum whereas oestradiol-17β values reached base values 24
hours after parturition. Both estrogen concentrations remained constant during the puerpe‐
rium until day 51 post partum (Meinecke-Tillrnann et al., 1983). This complete described es‐
trogene pattern is now a day well understood. In 2006, Senger clearly described the removal
of “progesterone block” that occurs during mammals gestation and necessary to start partu‐
rition. Fetal cortisol promotes the synthesis of three enzymes that convert P4 to E2. Proges‐
terone, that is high at the placenta interface (from gonadal or placental origin depending on
the species, as explained before), is converted to 17 alpha-hydroxy-P4 by the enzyme 17al‐
pha-hydroxylase. Fetal cortisol also induce the production of 17-20 desmolase to produce
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androstenedione from the 17 alpha-hydroxy-P4 and then the induced enzyme aromatase
converts androstenedione to estrogens; that is at the end a dramatic drop in P4 and a dra‐
matic elevation in E2. The consecuences are that myometrium becomes increasingly more
active and displays noticeable contractions. At the same time, fetal cortisol induces placental
production of PGf2a which initiates the luteolytic process, contributing to the decrease of
gonadal P4 production. Sex steroids and oxytocin (OT) produced within intrauterine tissues
have been implicated in the regulation of parturition. Fang et al. performed very complete
studies to determine the relationships among E2, P4, OT, and their receptors in uterine tis‐
sues during late gestation and parturition in the rat; to observe the effects of the estrogen
antagonist tamoxifen (TAM) on these factors; and to evaluate the rat as a potential model for
events at human parturition. Serum E2 increased throughout late gestation accompanied by
an increase in uterine OT mRNA and ER. Serum P4 declined after day 19, and uterine PR
did not change significantly. Uterine PGE2 increased progressively, reaching peak levels the
evening before delivery. Uterine OTR did not increase until the morning of delivery, and
uterine OT peptide concentrations increased only during parturition. Parturition was signifi‐
cantly delayed by 24 h in the TAM-treated group. TAM inhibited the increase in serum E2,
uterine ER, and OT mRNA and peptide, but had no effect on serum P4 or uterine PR levels.
With TAM, the responses of uterine OTR and prostaglandin E2 (PGE2) were significantly
delayed, but still underwent a significant increase before the delayed parturition. These re‐
sults supported that indeed E2 stimulates the synthesis of ER, OT, and OTR within the rat
uterus and is essential for normal parturition. P4 withdrawal may be more important to the
increases in OTR and PGE2, but these are delayed in the absence of estrogen (Fang et al.,
1996). The precise temporal control of uterine contractility is essential for the success of
pregnancy. For most of pregnancy, progesterone acting through genomic and non-genomic
mechanisms promotes myometrial relaxation. At parturition the relaxatory actions of pro‐
gesterone are nullified and the combined stimulatory actions of estrogens and other factors
such as myometrial distention and immune/inflammatory cytokines, transform the myome‐
trium to a highly contractile and excitable state leading to labor and delivery. Steroid hor‐
mone control myometrial contractility and parturition as part of the parturition cascade.
(Mesiano and Welsh, 2007). The compulsory progesterone withdrawal necessary for deliv‐
eru take place is mediated by changes in myometrial expression of progesterone receptors
(PRs)-a and –b. This withdrawal in human parturition may be mediated by an increase in
the myometrial PR-a to PR-b ratio due to increased PR-a expression affecting myometrial
cell progesterone responsiveness (Merlino et al., 2007) (Table2).
3.4.5. Puerperium or postpartum
In domestic animals, puerperium begins immediately after parturition and lasts until repro‐
ductive function in restored so that another ovulation occurs and other potential pregnancy
can take place. The time required for complete uterine repair and ovarian activity to resume
in the postpartum female varies significantly among species (beef cows: 30d and 50-60d; dai‐
ry cows: 45-50d and 25d; ewe: 30d and 180d; mare: 28d and 12 d; sow: 30d and 7d; queen:
30d and 30d; bitch: 90d and 150d, a long natural postpartum anestrus). In beef cow, sows
and women, the lactation inhibits ovarian activity (Senger, 2006). Also, manipulation of ab‐
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normal anestrus in ruminants with sex steroids implants (P4,E2), intra muscular or intrava‐
ginal devices during postpartum are intended in order to shortening or at least to be near
the normal period required to re-produce.
In beef cows (zebu-Bos indicus cattle), in some environmental conditions, the interval partu‐
rition-ovarian reactivation (anestrous period) and the abnormal sex steroids production rep‐
resent a big economical problem (180-240 d, vs. 60d theorical proposed (Senger, 2006))
because animals are not producing during this large interval and the “physiological” goal of
one calf a cow a year is not reached at all. This was investigated many years ago in the follic‐
ular morfological and steroids dynamics aspects concluding about very individual patterns
and about the potential early capacity of initiating ovarian activity depending on many fac‐
tors (Ruiz-Cortes and Olivera-Angel, 1999). The return to the ovarian activity postpartum, is
determined by the recovery of the hipotalamic-hipofisis-ovary axis and mainly by three fac‐
tors: (a) nutrition, by the secretion of leptin from adipocites, (b) suckling, by prolactin pro‐
duction and (c) the cow-calf link, mediated by the senses of the vision and smell. In
addition, after ovarian recovery postpartum, the cows present low fertility associated with
corpus luteum of short duration and low production of P4. The induction of estrus with pro‐
gestins has generated corpus luteum of normal duration, in response to the weaning or to
the injection of gonadotrophins. Zebu cows postpartum, were treated with progestins and
with temporal suckling interruption (TSI):calves-cows separation, for 72 hours. We could
conclude that the treatment with TSI solely or in combination with progestins, can induce
estrus, ovulation and corpus luteum of good quality, in postpartum Zebu cows. This useful
tool for shortennig calving intervals is now a day used with success by local farmers (Giral‐
do Echeverri et al., 2005).
Those features indicate mainly the multifactorial effects of the peripartum on the sex ste‐
roids production, but also the gonadal steroids important role in the pospartum cyclicity re‐
activation.
High levels of E2 near the delivery and some days after are also regulating the OTR expres‐
sion and the OT and effects myometrium. Thus contractions needed for the placenta mem‐
branes and lochia (blood-tinged fluid containing remnants of the fetal placenta and
endometrial tissue) discharge in the early postpartum occurs (Table 2).
Studies in primates have suggested that pre- and peripartum sex steroid hormones may be
important determinants of maternal behavior and motivation, since higher levels of prepar‐
tum estrogen are associated with maternal competency and infant survivorship. The re‐
searchers found that high concentrations of prepartum E2 in callitrichid primates are not
necessarily associated with competent maternal behavior and may instead be associated
with poor infant survivorship and inadequate maternal care. That appears to be convergent
with research focusing on human mothers and may represent a common underlying mecha‐
nism linking prepartum estrogen and postpartum affect and behavior in some primates.
Similary, in males of this specie, T, and possibly E2, play an important role in balancing the
expression of paternal care with that of other reproductive behavior (Fite and French, 2000;
Nunes et al., 2000).
Gonadal Sex Steroids: Production, Action and Interactions in Mammals
http://dx.doi.org/10.5772/52994
27
3.4.6. Lactation
The importance of the sex steroid hormones E2 and P4 for normal development of the mam‐
mary gland was recognized several decades ago and has been unequivocally confirmed
since. This influence is not restricted to mammogenesis, but these hormones also control in‐
volution. Growth factors also have been shown to modulate survival (epidermal growth fac‐
tor, amphiregulin, transforming growth factor α, insulin like growth factor, and tumor
necrosis factor α) or apoptosis (tumor necrosis factor α, transforming growth factor β) of
mammary cells. Lamote et al. published in a review about the interaction between both
groups of modulators as an important functional role for sex steroid hormones in the lacta‐
tion cycle in co-operation with growth factors. At that time the molecular mechanism under‐
lying the influence of sex steroid hormones and/or growth factors on the development and
function of the mammary gland remained largely unknown (Lamote et al., 2004).
Nevertheless, in a model of in vitro mammary gland involution (mammary epithelial cells –
MEC) where authors were interested in the autophagy and the apoptosis occurring during in‐
volution, they concluded about important molecular pathways explaining the sex steroids-
growth factors cross-talk during lactation and involution. They investigated the effects of
insulin-like growth factor-1 (IGF-I) and epidermal growth factor (EGF) signaling, as well as
sex steroids on autophagy focusing about the role regulatory role of mTOR. The kinase mTOR
links IGF-I and EGF signaling in inhibiting the autophagy pathways. Contrary to IGF-I and
EGF, E2 and P4 exerted stimulatory effects on autophagy in bovine MEC. At the same time, it
was a suppressive effect of both steroids on mTOR activation/phosphorylation. In conclu‐
sion, autophagy in bovine MEC undergoes complex regulation, where its activity is control‐
led by survival pathways dependent on IGF-I and EGF, which are involved in suppression of
autophagy, and by pregnancy steroids, which act as inducers of the process (Sobolewska et
al., 2009). Probably mammogenesis is also regulated by similar kinase pathway, and this is a
clue finding to better understand sex regulation of mammalian lactation (Table 2).
Ovarian steroids (E2 and P4) diffuse directly from the blood into milk by passive diffusion
because they are lipid soluble. All steroids hormones can be found in milk. The concentra‐
tion of E2 and P4 in milk reflects cyclic hormone production by the ovaries and is highly
correlated with blood concentrations. Such a phenomenon enables steroids (particulary P4)
to be easely assayed in milk to determine the reproductive status of the female. In cows, the
ELISA technology enables P4 levels in milk to be determined. The measurement of P4 in
each milking through the use of “in-line“ assay technology in the milking parlor is a revolu‐
tionary goal to achieve for research and for farmers producers management. The develop‐
ment of such technology would enable the producer to determine whether a cow is cycling,
the stage of estrous cycle, pregnancy status and some form of ovarian pathology (v.g. cystic
ovarian desease), for each cow, on a daily basis (Senger, 2006).
3.4.7. Menopause and andropause
Menopause is defined as the permanent cessation of menstruation resulting from the loss of
ovarian follicular activity and marks the end of natural female reproductive life. Menopause
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is preceded by a period of menstrual cycle irregularity, known as the menopause transition
or peri-menopause, which usually begins in the mid-40s. The menopause transition is char‐
acterized by many hormonal changes predominantly caused by a marked decline in the
ovarian follicle numbers. A significant decrease in inhibin B appears to be the first endocrine
marker of the menopause transition with FSH levels being slightly raised. Marked decreases
in estrogen and inhibin A with significant increases in FSH are only observed in the late
stage of menopause transition. At the time of menopause, FSH levels have been shown to
increase to 50% of final post-menopausal concentrations while estrogens levels have de‐
creased to approximately 50% of the premenopausal concentrations. Since the decrease in
estrogen levels occurs in the fifth decade of life, this means that most women will spend
more than 30 years in postmenopausal status. A good body of evidence suggests that
changes in hormonal status, particularly the decline in estrogen, in the menopause years
may have a detrimental effect on women’s health (Table 2). Accordingly, it has been report‐
ed that the decrease in estrogen contributes to the decrease in bone mass density, the redis‐
tribution of subcutaneous fat to the visceral area, the increased risk of cardiovascular disease
and the decrease in quality of life.
In addition, hormonal changes may also have a direct effect on muscle mass. The measure‐
ment of urinary estrogens metabolites could add new evidence as for the role of estrogens in
sarcopenia. It remains certain, though, that the decline in muscle mass is associated with an
increased risk of functional impairment and physical disability. Finally, further randomized
controlled trials are needed to investigate the effects of physical activity as well as hormone
and phytoestrogen supplementation on sarcopenia (Messier et al., 2011).
Hot flushes common in almost 85% of women, appear to result from a dysfunction of ther‐
moregulatory centers in the hypothalamus and are correlated with pulses of circulating es‐
trogen and gonadotropin secretion in menopausal women (López et al., 2000).
A recent review of literature from 1990 until 2010, compare oral and transdermal delivery
systems for postmenopausal estrogen therapy in domains of lipid effects; cardiovascular, in‐
flammatory, and thrombotic effects; effect on insulin-like growth factor, insulin resistance,
and metabolic syndrome; sexual effects; metabolic effects including weight; and effects on
target organs bone, breast, and uterus.
Significant differences appear to exist between oral and transdermal estrogens in terms of hor‐
monal bioavailability and metabolism, with implications for clinical efficacy, potential side ef‐
fects, and risk profile of different hormone therapy options, but as neither results nor study
designs were uniform, not complete conclusions could be done. Weight gain appears to be
slightly lower with a transdermal delivery system. Oral estrogen's significant increase in hep‐
atic sex hormone binding globulin production lowers testosterone availability compared with
transdermal delivery, with clinically relevant effects on sexual vigor (Goodman, 2012).
The relationship between menopause and cognitive decline has been the subject of intense
research since a number of studies have shown that hormone replacement therapy could re‐
duce the risk of developing Alzheimer’s disease (AD) in women. In contrast, research into
andropause has only recently begun. Furthermore, evidence now suggests that steroidogen‐
esis is not restricted to the gonads and adrenals, and that the brain is capable of producing
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its own steroid hormones, including testosterone and estrogen (Bates et al., 2005). Male ag‐
ing is associated with a variable but generally gradual decline in androgen activity, which
can manifest as sexual dysfunction, lethargy, loss of muscle and bone mass, increased frail‐
ty, loss of balance, cognitive impairment and decreased general well-being, such as depres‐
sion and irritability. Andropause is defined as the partial or relative deficiency of androgens
and characteristic associated symptoms. These symptoms suggest that androgens may have
an important modulatory role in cognition and mental health. Indeed memory loss was the
third most common reported symptom of andropause, after erectile dysfunction and general
weakness in a survey of elderly men (Bates et al., 2005).
Mild cognitive impairment (MCI) is becoming fashionable as a diagnosis, representing a
state of cognitive decline associated with negligible functional loss. MCI is important as it
often precedes Alzheimer disease (AD). Recognizing MCI may lead to preventive strategies
that can delay the onset of AD. Many patients in transition into andropause report problems
with their memory. There is strong evidence from basic sciences and epidemiological stud‐
ies that both estrogens and androgens play a protective role in neurodegeneration. The evi‐
dence from small prospective clinical trials lends support to the role of hormones in
improving cognitive function. Patients have reported memory improvements in both declar‐
ative and procedural domains after being on hormonal replacement. Authors have hypothe‐
sized androgens and perhaps selective androgen receptor modulators as future treatment
options for MCI in aging males (Tan et al., 2003).
Moment Definition* Estradiol-E2
(effects, target tissues)
Progesterone-P4
(effects, target
tissues)
Testosterone-T
(effects, target tissues)
Puberty Acquisition of
gonadotropin secretion,
gametogenesis,
gonadal steroids
secretion, reproductive
behaviour and
secondary sex
Pituitary, Hypothalamus.
Increase responsiveness
to GnRH
Increase of GH
Increase of IGF-I
Genital enlargement
Muscle strength
Body composition
Spermatogenesis
Fertilizati
on
The process of
combining the male
gamete, or sperm, with
the female gamete, or
ovum. The product of
fertilization is a cell
called a zygote
Oocytes.
Inhibits abnormalities
Stimulates maturation
Success of fertilization
Acrosome reaction
Oocytes.
Inhibits
abnormalities
Stimulates
maturation
Spermatozoa.
Acrosome reaction
Oocytes.
Inhibits
abnormalities
Stimulates
maturation
Success of
fertilization
Gesta-
tion
Pregnancy. The period
that a female is
pregnant between
conception and
parturition
Myometrium,
decreases
contractions
Endometrium,
“maternal”
secretions
Placen-
tation
The structural
organization and
physical relationship of
the fetal membranes to
the endometrium that
placenta
Control of placental mass
Inhibit 17a-hydroxylase
expression in the
placenta
Immunosuppressant
of the placenta
Ovary. Cross talk
with
placental androgens
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Moment Definition* Estradiol-E2
(effects, target tissues)
Progesterone-P4
(effects, target
tissues)
Testosterone-T
(effects, target tissues)
provides the site of
metabolic exchange
between the dam and
the fetus
Parturi-
tion
To give birth Ovary. Increases, OTR,
production of PF2a
Endometrium. Increases
lubrication
Myometrium. Increases
ER, OTR, Increases
contractions
Hypothalamus. Increases
OT secretion
Ovary. Converted to
E2
Postpar-
tum or
puerpe-
rium
The period between
parturition and return
to the normal cycling
state of the ovaries and
uterus
Brain. Male and female.
Maternal and paternal
behavior
Endometrium.
Myometrium.Contraction
s and placental
membranes and loquia
expulsion
Ovary: cross-talk with P4
Ovary. Croos –talk
with E2
Hypothalamus, Gn
RH production
control
Paternal behavior
Lactation Formation and /or
secretion of milk by the
mammary glands
Mammary gland:
development,
mammogenesis
Cross-talk with IGF-I and
EGF: modulation of
lactation and involution
(autophagy)
Mammary gland:
development,
mammogenesis
Cross-talk with IGF-I
and EGF:
modulation of
lactation and
involution
(autophagy)
Mammary gland:
development,
mammogenesis
Cross-talk with IGF-I
and EGF:
modulation of
lactation and
involution
(autophagy)
Meno-
pause
Permanent cessation of
menses; termination of
menstrual cycles
brought about by
depletion of ovarian
follicles
Bone. Regulates bone
mass
Muscle. Regulates muscle
mass
Subcutaneous visceral fat
Heart:cardiovascular
desease
Brain: hot flushes,
depression,irritability
Andro-
pause
A variable complex of
symptoms, including
decreased Leydig
cell numbers
and androgen producti
on, occurring in men
after middle age
Bone. Mass loss
Muscle. Mass loss
Reprod. Tract.erectil
dysfunction
Brain. Memory loss,
cognitive
impairment
*modified from Senger, 2006
Table 2. Gonadal steroids regulation of clue reproductive moments. Definitions, target tissues and main sex steroids
effects
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4. Gonadal steroid hormones action on other systems
4.1. Energy homeostasis, sex hormones implications
Since the adipose tissue hormone leptin was discovered in 1996, its energy balance regula‐
tory  effects  have  been  well  investigated  and accepted.  The  interaction  of  leptin  and its
membrane receptors within different systems were also the focus of interest of many re‐
searches making the protein and the receptor almost ubiquitous in mammals. Thus, it is
of big interest the relationship of leptin with sex steroids. Early in this chapter, it was de‐
scribed how leptin regulates gonadal steroidogenesis (Montaño et al., 2009; Ruiz-Cortes et
al.,  2003;  Ruiz-Cortes  and  Olivera,  2010).  However,  in  2000,  Mystkowski  and  Schwartz
postulated also that sex steroids and leptin regulate one another’s production. Although
gonadal steroids, unlike leptin, are clearly not critical to the maintenance of normal ener‐
gy homeostasis, they do appear to function as physiologic modulators of this process. Go‐
nadal steroids influence food intake and body weight. Although the specific mechanisms
underlying these effects are not clear, a consideration of their effects in the context of cur‐
rent  models  of  energy  homeostasis  may  ultimately  lead  to  the  identification  of  these
mechanisms. When compared with leptin, the prototypical humoral signal of energy bal‐
ance, sex steroids share many common properties related to food intake and body weight.
Specifically,  gonadal steroids circulate in proportion to fat mass and current energy bal‐
ance, and administration of these compounds influences food intake, energy expenditure,
body weight, and body composition. Moreover, both estrogens and androgens modulate
central  nervous system effectors of  energy homeostasis  that  are targets for the action of
leptin,  including pathways that  contain  neuropeptide  Y,  pro-opiomelanocortin,  or  mela‐
nin-concentrating hormone (Mystkowski and Schwartz, 2000).
Several studies have reported decreased circulating estradiol levels in type 1 and type 2 dia‐
betic animal models. Women with type 1 diabetes experience decreased sexual arousal func‐
tion and have significantly reduced E2 levels compared to control subjects. Limited data are
available in type 2 diabetic women. It was proposed that diabetes disrupts estrogen signal‐
ing. This hypothesis was partially supported by studies showing that E2 supplementation in
diabetic animals ameliorates some of the diabetic complications in several organs and tis‐
sues, including those that control anabolic and catabolic pathways (food intake and energy
expenditure) such as melanocortin in the hypothalamic arcuate nucleus and neurons con‐
taining neuropeptide Y. No studies are available on the therapeutic effects of estradiol sup‐
plementation in type 2 diabetic animals in ameliorating the changes in sex steroid receptor
expression and tissue localization and distribution. For these reasons, researchers undertook
studies to investigate the effects of type 2 diabetes on the expression, localization and distri‐
bution of estrogen, androgen and P4 receptors and to determine if E2 treatment of diabetic
animals normalizes these changes. They found decreased levels of plasma E2 and reduced
ER expression in type 1 and type 2 diabetic animals suggesting that estrogen signaling is im‐
paired in the diabetic state. They conclude specifically, in a vaginal model, that sex steroid
hormone receptor signaling is important in female genital sexual arousal function. These
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findings further demonstrate that E2 supplementation provides a protective effect by up-
regulating the expression of sex steroid receptor proteins (Cushman et al., 2009).
Important tissues implicated in homeostasis are fat mass and muscle mass. Effects of andro‐
gens in those systems are well known. As general information, males typically have less
body fat than females. Recent results indicate that androgens inhibit the ability of some fat
cells to store lipids by blocking a signal transduction pathway that normally supports adipo‐
cyte function. Also, androgens, but not estrogens, increase beta adrenergic receptors while
decreasing alpha adrenergic receptors resulting in increased levels of epinephrine/ norepi‐
nephrine due to lack of alpha-2 receptor negative feedback and decreased fat accumulation
due to epinephrine/ norepinephrine then acting on lipolysis-inducing beta receptors.
About androgens and muscle mass, it is clear that males typically have more skeletal muscle
mass than females and this is because androgens promote the enlargement of skeletal mus‐
cle cells and probably act in a coordinated manner to function by acting on several cell types
in skeletal muscle tissue. One type of cell that conveys hormone signals to generating mus‐
cle is the myoblast. Higher androgen levels lead to increased expression of androgen recep‐
tor. Fusion of myoblasts generates myotubes, in a process that is linked to androgen
receptor levels much more expressed in males but also having effect in females (Figure 6).
Sex hormones play essential roles in the regulation of appetite, eating behaviour and energy
metabolism and have been implicated in several major clinical disorders in women. Estro‐
gen inhibits food intake, whereas progesterone and testosterone may stimulate appetite. In‐
teractions between sex hormones and neuroendocrinological mechanisms in the control of
appetite and eating in women have been recently reviewed. Hirschberg indicates that the
roles played by sex hormones in the development of eating disorders and obesity are clearer
now a days. For instance, androgens may promote bulimia by stimulating appetite and re‐
ducing impulse control, a proposal supported by the observation that antiandrogenic treat‐
ment attenuates bulimic behaviour. Androgens are also involved in the pathophysiology of
abdominal obesity in women. On the other hand, hormone replacement therapy with estro‐
gen counteracts the weight gain and accumulation of abdominal fat associated with the
menopausal transition. The author conclude that sex hormones and/or agents that exhibit
similar activities may provide novel strategies for the treatment of eating disorders and an‐
droid obesity, two of the most serious health problems for women today (Hirschberg, 2012).
4.2. Cardiovascular system
Sex steroids effects, as reviewed in the sex steroids molecular pathways section, have “the
long” pathway and the rapid one. In the case of the cardiovascular system in mammals,
the rapid non-transcriptional is the mechanism that explains the implications of gonadal
steroids.
Traish et al. have recently reviewed the topic of androgens modulation of the lipid profiles
and contribution to development and progression of atherosclerosis. They found studies in
animals and humans suggesting that androgen deficiency is associated with increased tri‐
glycerides (TGs), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C). Al‐
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though the effects of androgen deficiency on high-density lipoprotein cholesterol (HDL-C)
remains controversial, recent data suggest that androgen therapy is associated with in‐
creased levels of HDL-C and may improve reverse cholesterol transport. Animal studies
suggested that androgen deprivation adversely affect lipid profiles and this was reversed by
androgen treatment. Furthermore, androgen treatment of hypogonadal men significantly
improved lipid profiles. Emerging data indicate that androgens play an important role in
lipid metabolism. Therefore androgens are critical in the prevention and progression of
atherosclerosis (Traish et al., 2009a).
Androgen deficiency contributes to increased TGs, TC, LDL-C and reduced HDL-C while
androgen treatment results in a favorable lipid profile, suggesting that androgens may pro‐
vide a protective effect against the development and/or progression of atherosclerosis.
Until recently, it was thought that male gender contributes to the risk of atherosclerosis and
this was attributed to androgens. Evidence is emerging that androgen deficiency is more
likely to be associated with atherosclerosis than gender per se. T treatment of hypogonadal
men resulted in reduced pro-inflammatory cytokines, total cholesterol, and triglyceride lev‐
els. In women,T use was reported for sexual dysfunction, abnormal uterine bleeding, dys‐
menorrhea, menopausal symptoms, chronic mastitis and lactation, and benign and
malignant tumors of the breast, uterus, and ovaries (Traish et al., 2009b). However, these au‐
thors literally conclude: “health-care professionals engaged in the management of women's
health issues have observed the benefits of androgen therapy throughout much of the 20th
century. Despite this clinical use of testosterone in women for more than seven decades,
contemporary testosterone therapy in women is hotly debated, misunderstood, and often
misrepresented in the medical community”(Traish et al., 2009b).
New evidence suggests that androgen deficiency alters lipid profiles, which ultimately con‐
tribute to oxidative stress, endothelial dysfunction and increased production of pro-inflam‐
matory factors, thus promoting the pathogenic process leading to atherosclerosis (Figure 6).
Future research should focus on delineating the physiological or biochemical mechanisms
and should focus on the molecular basis of androgen action in regulating lipid metabolism
and endothelial function in order to have a better understanding of the role of androgens,
deficiency and vascular diseases (Traish et al., 2009a).
4.3. Sex steroids, the brain and behavior
Almost all the sex steroids have something to do with the brain. It is maybe because of this
part of the pathway that they are so important in the mammals general physiology (Figure 6).
Circulating levels of androgens can influence human behavior because some neurons are
sensitive to steroid hormones. Androgen levels have been implicated in the regulation of
human aggression and libido (Figure 6). Indeed, androgens are capable of altering the struc‐
ture of the brain in several species, including mice, rats, and primates, producing sex differ‐
ences. Numerous reports have outlined that androgens alone are capable of altering the
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structure of the brain; however, it is difficult to identify which alterations in neuro-anatomy
stem from androgens or estrogens, because of their potential for conversion.
Estrogens are effective regulators of brain cell morphology and tissue organization through
the regulation of the cytoskeleton. Many of these regulatory actions related to cell morphol‐
ogy are achieved through rapid, non-classical signaling of sex steroid receptors to kinase
cascades, independently from nuclear alteration of gene expression or protein synthesis.
Brain cell morphology is then reported to be controlled by estrogens that regulate the devel‐
opment of neuron/neuron interconnections and dendritic spine density.This is thought to be
critical for gender-specific differences in brain function and dysfunction. The recent ad‐
vancements in the characterization of the molecular basis of the extra-nuclear signaling of
estrogen helps to understand the role of estrogen in the brain and central nervous system,
and may in the future turn out to be of relevance for clinical purposes (Sanchez and Simon‐
cini, 2010).
Studies in animals have made abundantly clear the important role played by gonadal ste‐
roids in the regulation of behavior. Given the importance of reproductive behavior in the
survival of the species, the potency and range (e.g., learning and memory, appetite, aggres‐
sion, affiliation) of these behavioral effects are not surprising. The role of gonadal steroids in
human behavior is both more complex and more poorly delineated.
The role of gonadal steroids in behavior in men and women include the exquisite context
dependency of responses to gonadal steroid signals and the role of both gonadal steroids
and context in several reproductive endocrine-related mood disorders such as menstrual cy‐
cle-related mood disorders, perimenopausal and periandropause depression, postpartum
depression, hormone replacement therapy-related dysphoria, androgen-anabolic replace‐
ment, use or abuse(Rubinow et al., 2002).
Depression is more common in women, and women appear to respond better to selective
serotonin reuptake inhibitors (SSRIs) than men. In addition, SSRIs are an excellent treatment
for premenstrual dysphoria disorder. Thus, a sex specific effect of E2 and P4 on function of
the serotonin transporter is quite important. However, the effect is the opposite of what
would be predicted from the clinical literature, further underscoring the complexity of un‐
derstanding the interactions between ovarian hormones and serotonin systems. Perhaps
these findings help to better understand the vulnerability to mood disorders at times when
E2 and P4 are high, such as the luteal phase of the menstrual cycle. Of note is the fact that
these changes in response to E2 and P4 were not observed in hippocampi of male (Young
and Becker, 2009).
In domestic animals the reproductive bevavior can take place only if the neurons in the hy‐
pothalamus have been sensitized to respond to sensory signals. T in the male is aromatized
to E2 in the brain and E2 promotes reproductive behavior. In the male there is a relatively
constant supply of T (every 4 to 6 h) and thus E2, to the hypothalamus. This allows the male
to initiate reproductive behavior at any time. In contrast the female experiences high E2 dur‐
ing follicular phase only and will display sexual receptivity during estrus only. Under E2
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influence, sensory inputs such as olfaction, audition, vision, and tactility send neural mes‐
sages to the hypothalamus and cause the release of behavior specific peptides or neurotrans‐
mitters. In the mid brain, those hypothalamic signals are translated into fast responses.
Synapsis between neurons of the mid brain and neurons in the medulla transmit the signal
to the spinal cord and then to motor neurons that innervate muscles as during the lordosis
and mounting occurring in domestic animals (Senger, 2006)
4.4. Gonadal steroids on bone turnover
In a very complete and recent review paper, Karsenty proposed that the well recognized sex
steroid hormones regulation of bone mass accrual, is essential for skeletal development and
maintenance of bone health throughout adult. Testosterone and estrogen positively influ‐
ence growth, maturation, and maintenance of the female and male skeleton. Their effects are
mediated mainly by slow genomic mechanisms through nuclear hormonal receptors, and
possibly through the fast nongenomic mechanisms by membrane associated receptors and
signaling cascades. But, on the other hand, the authors exposes the hypothesis that bone
may regulates the female fertility by osteocalcin and that osteocalcin signaling in Leydig
cells of the testis as a novel mode of regulation of testosterone synthesis observed in males
but not in females (Karsenty, 2012 ).
Sex steroids play an important role in bone growth and the attainment of peak bone mass.
They are, at least in part, responsible for the gender differences in bone growth, which
emerges during adolescence. The skeletal sexual dimorphism is mainly due to a stimulatory
androgen action on periosteal bone formation in men, whereas an inhibitory estrogen-relat‐
ed action occurs in women (Karsenty, 2012 ; Venken et al., 2006). In addition to the sex ste‐
roid hormones, several studies have shown that other hormones negatively regulated by
estrogen, such as growth hormone (GH) and insulin-like growth factor 1 (IGF1), may further
contribute to the development of the skeletal sexual dimorphism. Sex steroid hormones
maintain skeletal integrity.
Testosterone and estrogens are also crucial for maintaining bone mass accrual during adult‐
hood in the female and male skeleton. The loss of ovarian function underlies the develop‐
ment of osteoporosis (Karsenty, 2012 ; Vanderschueren et al., 2004). Estrogen deficiency is a
major pathogenic factor in the bone loss associated with menopause and the development of
osteoporosis in postmenopausal women. This rapid bone loss can be prevented by estrogen
administration, and characteristically results in an increase in bone mineral density during
the first months of treatment. Additionally, the loss of testicular function also underlies bone
loss in men. Although osteoporosis more commonly affects women, the loss of androgens in
males following castration or a decrease in androgen levels related to aging, during andro‐
pause, has the same dramatic effect on the skeleton. Androgens favor periostal bone forma‐
tion in men, and maintain trabecular bone mass and integrity (Karsenty, 2012 ;
Vanderschueren et al., 2004)(Figure 6).
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Figure 6. Sex steroids effects in different systems, a general view in mammals. Sex steroids produced in ovary and tes‐
tis are regulating different organs and tissues in the brain (behavior,menopause,andropause), food intake and general
homeostasis, cardiovascular system, muscle, fat and bone mass.
Gonadal Sex Steroids: Production, Action and Interactions in Mammals
http://dx.doi.org/10.5772/52994
37
5. Conclusions and perspectives
Paraphrasing a paper first sentence: “Sex matters to every cell of the body” (Young and
Becker, 2009) and gonadal steroids are mediating such a huge task. Since the discovery of
those hormones (eighteen century), androgens, estrogens and progestogens, were classified
more in a sex manner. It is well known now that males and females share the steroidogene‐
sis pathways and sex steroids effects in many organs and systems such as the brain, muscle,
fat, bone, reproductive system, cardiovascular system, homeostasis system (body weight-
composition, food intake). The unraveling of this complex panorama of action and interac‐
tion of gonadal sex steroids indicates that almost no organ is left out of the sex hormones
scope. One the most interesting feature of sex steroids action are the alternates pathways
they are using to exert they modulating role by their membrane, cytoplasmic or nuclear re‐
ceptor molecular activation (rapid and/or genomic mechanism) or in the very pertinent
called “cross-talk” with other hormones, growth factors, transcription factors signaling path‐
ways. Organism are integrated entities fulfilling their specific functions, and not as isolated
group of distinct cell types (Karsenty, 2012 ) and it is amazing to realize how gonads via sex
steroids are able to modulate and integrate such an intrincate orchestra. From a molecular
point of view, the multiple signaling pathways already described for androgens and estro‐
gens and their interactions are just the beginning of the understanding of the complex cross
talk and interorgan connections. Some species can support gestation with just gonadal-cor‐
pus luteum P4 synthesis; other early during pregnancy can afford ovariectomy and the pla‐
centa would replace the steroid production. This turnover do not occur as an isolated event
but more as unique interaction or cross-talk between placenta and ovaries (placental andro‐
gens aromatized in the ovary); similar interaction is happening between ovarian theca and
granulosa cells and between Leydig and Sertoli testicular cells where androgens synthesis
and aromatization to estradiol take place in a paracrine manner. Other amazing phenomen‐
um is the autocrine dialogue in granulosa cells during luteinization, where granulosa pro‐
ducing high concentration of E2 switch their steroid production to P4 secretion. Again in
this case the molecular machinery implicated in the sex steroid production is model of ver‐
satility and adaptation. Thus, the evolutionary aspect should be taken also in account for fu‐
ture studies about the cellular and molecular pathways of gonadal sex steroids action and
interaction in mammals.
There are still several pieces of the puzzle that are to be found. Perspective to further re‐
search includes studies on the new class of steroid receptors (implicated in the rapid action
signaling); the exact role of E2 and inhibin in male reproduction; the anabolic synthetic
products:use and abuse; the therapy of replacement in menopause and andropause: what is
worst the loss of sex steroids, or the “non-natural” replacement therapy with cancer risk?
What is the matter, the delivery system, the doses, the compounds (what about phytothera‐
py?), the duration of the treatment, the human being individuality and conscience? In do‐
mestic animals, sex steroids therapies, to regulate cyclicity or even to make monovulatory
animals to superovulate, are very common practice and collateral effects are rare or inexis‐
tent. Of course, they are not long treatment but instead they are performed very frequently
with remarkable positive results. The ultimate purpose of this review was not to propose the
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ideal steroid therapy or to give all the molecular factors implicated in the action and interac‐
tion of sex steroids in mammals. However, it could allow a better understanding of the
panoply of effects in reproductive and other systems.
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